Drug ID: | NPD2094 |
Drug Name: | Orilotimod |
Molecular Formula: | C16H19N3O5 |
Canonical SMILES: | OC(=N[C@@H](C(=O)O)Cc1c[nH]c2c1cccc2)CC[C@H](C(=O)O)N |
Standard InCHI: | InChI=1S/C16H19N3O5/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24)/t11-,13-/m1/s1 |
Standard InCHIKey: | CATMPQFFVNKDEY-DGCLKSJQSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB012923 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 333.13 |
ALogP | -2.2365 |
MLogP | 2.34 |
XLogP | -1.607 |
HDA | 8 |
HBD | 5 |
Rotatable Bonds | 12 |
TPSA | 149 |
RO5 Violation | 0 |